Cargando…
A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR
Pathophysiology associated with Huntington’s disease (HD) has been studied extensively in various cell and animal models since the 1993 discovery of the mutant huntingtin (mHtt) with abnormally expanded polyglutamine (polyQ) tracts as the causative factor. However, the sequence of early pathophysiol...
Autores principales: | Hung, Chiu-Yueh, Zhu, Chuanshu, Kittur, Farooqahmed S., He, Maotao, Arning, Erland, Zhang, Jianhui, Johnson, Asia J., Jawa, Gurpreet S., Thomas, Michelle D., Ding, Tomas T., Xie, Jiahua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576654/ https://www.ncbi.nlm.nih.gov/pubmed/36251090 http://dx.doi.org/10.1007/s00018-022-04587-6 |
Ejemplares similares
-
Regulation of one-carbon metabolism may open new avenues to slow down the initiation and progression of Huntington’s disease
por: Xie, Jiahua, et al.
Publicado: (2023) -
Rethinking the necessity of low glucose intervention for cerebral ischemia/reperfusion injury
por: Xie, Jiahua, et al.
Publicado: (2021) -
Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
por: Kittur, Farooqahmed S., et al.
Publicado: (2023) -
Plant-Produced Asialo-Erythropoietin Restores Pancreatic Beta-Cell Function by Suppressing Mammalian Sterile-20-like Kinase (MST1) and Caspase-3 Activation
por: Arthur, Elena, et al.
Publicado: (2017) -
Recombinant asialoerythropoetin protects HL-1 cardiomyocytes from injury via suppression of Mst1 activation
por: Kittur, Farooqahmed S., et al.
Publicado: (2019)